The
GM2 gangliosidoses are a group of three related genetic disorders that result from a deficiency of the enzyme
beta-hexosaminidase. This
enzyme catalyzes the
biodegradation of fatty acid derivatives known as
gangliosides. The diseases are better known by their individual names.